Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001808665-24-000042
Filing Date
2024-11-12
Accepted
2024-11-12 08:28:45
Documents
101
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q asrt-20240930.htm   iXBRL 10-Q 1281426
2 EX-31.1 exhibit311-q32024.htm EX-31.1 11036
3 EX-31.2 exhibit312-q32024.htm EX-31.2 10951
4 EX-32.1 exhibit321-q32024.htm EX-32.1 5928
5 EX-32.2 exhibit322-q32024.htm EX-32.2 6162
  Complete submission text file 0001808665-24-000042.txt   7522135

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20240930.xsd EX-101.SCH 56042
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asrt-20240930_cal.xml EX-101.CAL 96072
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asrt-20240930_def.xml EX-101.DEF 263097
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20240930_lab.xml EX-101.LAB 590112
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20240930_pre.xml EX-101.PRE 437489
104 EXTRACTED XBRL INSTANCE DOCUMENT asrt-20240930_htm.xml XML 1208058
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39294 | Film No.: 241443723
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)